#JAAPA has published an article that examines some current literature on #DRSP #drospirenone pills entitled: “Do #Drospirenone Containing Oral Contraceptives Have a Higher Risk of #VTE?” Specifically, five (5) studies were reviewed and commented in in reaching an answer to the question posed by the title.
Combined oral contraceptives all have the potential to increase the risk of a #VTE or venous thromboembolism. This thoughtful analysis of current literature found that #DRSP pills should not be the first choice for most women. Rather, the author, Jennifer Hoffman Ribowsky, MS, RPA-C, concluded that it may simply be a reasonable choice for women with polycystic ovarian syndrome because of the antiandrogenic effects of #drospirenone. Existing data on the association between #VTE’s and #DRSP led the author to conclude it was not the choice for most women.
There are over 7,000 lawsuits arising out of the use of the #DRSP family of pills already pending in the US. Trials are scheduled in 2013 and alleged injuries include: death, strokes, pulmonary emboli, DVT, VTE’s, gallbladder removal, pancreatitis and related complications.
Gabriel F. Zambrano, P.A., is actively representing women that have suffered life altering injuries from the use of a #DRSP pill: #YAZ, #Yasmin, #Ocella, #BEYAZ & #SAFYRAL. Gabriel F. Zambrano, P.A., is the sponsor of this blog and commentary.
Bayer is the manufacturer of the novel family of #DRSP (#drospirenone) birth control pills that include: #YAZ #Yasmin #Ocella #BEYAZ and #SAFYRAL. The original Yasmin & YAZ pills, as well as certain generic versions, are the subject of alleged deaths, strokes, deep vein thrombosis, pulmonary emboli, cardiac events, gallbladder removal, pancreatitis and related medical complications, in the US. A Canadia Class Action is also pending with over 1,000 lawsuits.
A number of studies have come out in the past two years highlighting the potential increased risk of blood clots from DRSP pills. Yasmin & YAZ have been the subject of Four FDA Warning Letters, a #recall, $20M in fines for improper promotion, corrective TV ads, and Two changes in the warning label.
Gabriel F. Zambrano, P.A., has been investigating and representing girls and women that have suffered injuries from DRSP pills for the past three years. Additional, non-confidential information regarding the litigation, news reports and other issues is available at on Facebook at “Yasmin & YAZ Claims”
Serious risks from #NSAIDS include risks to otherwise healthy users. This was reported last June 2010 by USAToday in “Common Pain Relievers Raise Heart Risk for Healthy People” by E. Edelson. Yesterday, USAToday reported in “Study: Certain Painkillers Might Raise Odds of Stroke, Heart Attacks” that users with pre-existing conditions, as revealed by recent medical studies, are at risk for strokes or death. Given these articles, and cited studies, it appears that more information will be forthcoming regarding the risks NSAIDs, like #Aleve, #Advil, #Celebrex and #Motrin pose to consumers.
Popular #NSAIDS like #Aleve pose risks. USAToday reports certain painkillers may raise odds of stroke/heart attack
#DRSP birth control pill lawsuits continue to climb in US. Over 7,000 lawsuits pending. Lawsuits include claims for death, strokes, cardiac problems, pulmonary emboli, deep vein thrombosis, pancreatitis and gallbladder removal. Public links and information on the background to the litigation and non-confidential information via Yasmin & YAZ Claims and @yazattorney on Twitter.
Gabriel F Zambrano, P.A., is investigating cases, and representing girls, women and families that have suffered injuries, damages or loss of a loved one from DRSP pills and is the sponsor of this blog and commentary.
Over the counter #Acetaminophen products have new warnings this year. Know why? Liver failure, the need for liver transplants and deaths have prompted evaluation and action. News reports claim over 50,000 ER visits a year have a relationship with either over the counter products or prescription products with acetaminophen. Pictured in this photo is a Tylenol package with new warnings.
The FDA has initiated a multi-step change in labeling of #Acetaminophen #APAP over the counter and prescription pills. Watch this video for more info.
This video highlights how, and why, the FDA is working with manufacturers to change labeling. Liver failure can be fatal. Popular prescription pills already contain #APAP or #Acetaminophen and in combination can cause serious injuries or death. @gfzambrano
The Sponsor of this commentary, and reposting public service message from the FDA above, is Gabriel F. Zambrano, P.A. http://www.recallattorneys.co and is actively investigating serious injuries and deaths from the use of APAP or acetaminophen products before new labels and warnings were implemented.
OCELLA is a generic version of the DRSP (drospirenone) birth control pill family that includes: YAZ, Yasmin, BEYAZ & SAFYRAL. These are all trademarked by BAYER, while OCELLA is made for BARR, a TEVA company, by BAYER in Germany. The German factory was the subject of FDA inspections and warnings for failure to follow established protocol. There are presently over 7,000 lawsuits in the US regarding these pills, a class action in Canada. Wonder why? Alleged injuries include: Death, Strokes, Deep Vein Thrombosis, Pulmonary Emboli, Pancreatitis, Cardiac injuries or irregularities, Gallbladder removal and surgical complications. Need information ? http://www.yazclaims.com or click on the photo for info from http://www.yazlawsuits.co